| September 11, 2014 | ISSUE NUMBER 368 VOL 4 |
|
Special Feature
Pharm Exec’s Industry Audit 2014
2013 delivered a decisive stroke of good luck to the 27 companies participating in Pharm Exec's 13th Annual Industry Audit on shareholder performance. Revenues were up sharply from 2012's plunge into negative growth, but the turnaround accentuates a larger trend: the growing divide between Big Pharma and the smaller, more nimble players ...Read more
Training
Gain Competitive Advantage: Think Like a Navy SEAL
As well as the tough physical demands, US Navy SEAL training includes mental challenges such as “bulletproof mission planning” and “high-value target” selection. Pharma professionals would do well to apply these conceptual practices to establish a winning attitude in their industry, writes Stan Bernard ...Read more
Harness the power of your oncology data - Using data to produce customer insights through analytics is particularly challenging in oncology.
 Read this article
to learn how companies have captured the power of their oncology data and produced the right analytics to drive business results.
Training
Executive Coaching: Transforming Big Pharma from Within
Rick Koonce outlines the critical coaching steps to help top managers realize their potential in an industry undergoing significant restructuring of both human and financial capital
...Read more
Inspection Focus in Clinical Trials Using a Risk-Based Monitoring Approach
How will clinical trials that adopt an RBM approach be inspected? Covance shares actionable insights to start answering this vitally important question.  Learn more
Global
Ireland’s Celtic Tiger: Back on the Hunt
A panel of local leaders from industry, government, and the CRO community convened for a Pharm Exec roundtable to examine Ireland's future as a magnet for life science investments, and what the nation must do to remain the world’s leading exporter of finished pharmaceutical products
...Read more
Engineer Your Business to Win in the Mobile Selling Moment
Live Webinar: Thursday, September 25, 2014 12pm ET
Smartphones and tablets are becoming an extension of our brains. When we don’t immediately find what we want, we turn to our phone or tablet and look for a service to help. This is just as true for healthcare providers (HCPs) and employees as for consumers. In this webcast, you’ll learn to identify the mobile moments critical to engaging HCPs.
Register Free at  www.pharmexec.com/mobileselling
|
|
|
|
 //Afferent Pharmaceuticals (San Mateo, CA) named Kathleen Sereda Glaub as Chief Executive Officer.//Scott Peoples joined Marrone Bio Innovations (Davis, CA) as Vice President of Marketing.//AMAG Pharmaceuticals (Waltham, MA) announced the appointment of John A. Fallon, M.D., to its Board of Directors.//Batu Biologics (San Diego, CA) appointed Dr. Hong Ma as Chief Scientific Officer.//Catalyst Pharmaceutical Partners (Coral Gables, FL) announced the appointment of David D. Muth to the newly created position, Executive Vice President, Corporate Development.//
|
|
|
|
|
|
 |
|
 |
|
| |
|
 |
Which of these countries do you believe will drive most of pharma's growth over the next 12 months?
|
|
|
|
